Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Iodine	O
Containing	O
Agents	O
Classifier	O
Attending:	O
___.	O
Chief	O
Complaint:	O
shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
This	O
is	O
a	O
___	O
y/o	O
M	O
with	O
h/o	O
bronchiectasis,	O
s/p	O
RLL	O
lobectomy,	O
reactive	O
airway	O
disease,	O
FEV1	O
30%	O
predicted,	O
who	O
presents	O
with	O
complaint	O
of	O
increasing	O
shortness	O
of	O
breath	O
x	O
1	O
day.	O
Symptoms	O
started	O
with	O
URI	O
3	O
days	O
ago,	O
with	O
cough,	O
congestion,	O
low-grade	O
fever	O
and	O
night	O
sweats.	O
Called	O
into	O
triage	O
line	O
and	O
was	O
started	O
on	O
cefaclor	O
antibiotics	O
250mg	O
TID.	O
However	O
patient	O
reports	O
symptoms	O
persisted,	O
and	O
he	O
had	O
increasing	O
cough	O
with	O
episodes	O
of	O
mild	O
hemoptysis.	O
In	O
addition,	O
he	O
noted	O
increased	O
shortness	O
of	O
breath	O
such	O
that	O
he	O
becomes	O
short	O
of	O
breath	O
even	O
with	O
mild	O
exertion,	O
like	O
getting	O
out	O
of	O
bed	O
and	O
walking	O
to	O
the	O
door.	O
He	O
has	O
SOB	O
with	O
exertion	O
at	O
baseline,	O
however	O
usually	O
not	O
so	O
limited,	O
ie	O
able	O
to	O
walk	O
around	O
his	O
house	O
before	O
he	O
has	O
to	O
stop.	O
In	O
addition	O
he	O
feels	O
chest	O
tightness,	O
which	O
does	O
improve	O
transiently	O
when	O
he	O
takes	O
his	O
inhalers	O
(advair	O
or	O
combivent),	O
however	O
subsequently	O
returns.	O
He	O
reports	O
that	O
he	O
gets	O
similar	O
symptoms	O
once	O
a	O
year	O
in	O
the	O
winter	O
due	O
to	O
his	O
bronchiectasis.	O
Followed	O
by	O
Dr.	O
___	O
in	O
pulmonary.	O
He	O
does	O
not	O
require	O
o2	O
at	O
baseline	O
and	O
has	O
never	O
been	O
on	O
steroids	O
per	O
his	O
report.	O
.	O
In	O
ER,	O
no	O
leukocytosis,	O
normal	O
lactate.	O
given	O
combivent	O
nebs,	O
levofloxacin,	O
ceftriaxone.	O
CXR	O
negative	O
for	O
pna.	B-Lower_respiratory_tract_infection
CHest	O
CTA	O
negative	O
for	O
PE.	O
admit	O
to	O
medicine	O
On	O
arrival	O
to	O
floor,	O
feels	O
shortness	O
of	O
breath	O
even	O
when	O
sitting	O
up	O
to	O
side	O
of	O
bed,	O
also	O
still	O
with	O
chest	O
tightness/wheeze.	O
Coughing	O
up	O
scant	O
amounts	O
of	O
dark	O
blood	O
(___).	O
ROS:	O
+	O
fever,	O
night	O
sweats,	O
productive	O
cough,	O
chest	O
tightness.	O
Denies	O
nausea,	O
vomiting,	O
abdominal	O
pain,	O
brbpr,	B-Lower_gastrointestinal_haemorrhage
dysuria.	O
no	O
h/a,	O
vision	O
chages,	O
changes	O
in	O
mood.	O
no	O
new	O
brusing,	O
bleeding	O
or	O
change	O
in	O
bowel,	O
bladder	O
function.	O
chronic	O
bph,	O
gerd.	O
also	O
with	O
hernia.	O
Past	O
Medical	O
History:	O
urethral	O
stricture	O
s/p	O
laser	O
prostate	O
surgery	O
in	O
___	O
urethral	O
dilation	O
in	O
office	O
___	O
h/o	O
severe	O
bronchiectasis	O
requiring	O
RLL	O
lobectomy	O
as	O
a	O
child	O
h/o	O
seizures	B-Seizures
GERD	O
anxiety	O
depression	O
s/p	O
left	O
cataract	O
surgery	O
s/p	O
tonsillectomy	O
reactive	O
airways	O
Spirometry	O
___-	O
Spirometry	O
today	O
shows	O
FEV1	O
and	O
vital	O
capacity	O
0.71	O
and	O
1.24	O
(30%	O
and	O
33%	O
of	O
predicted	O
respectively).	O
FEV1	O
to	O
vital	O
capacity	O
ratio	O
is	O
90%	O
of	O
predicted	O
Social	O
History:	O
___	O
Family	O
History:	O
1.	O
Uterine	O
CA:	O
mother	O
2.	O
Breast	O
CA:	O
sister	O
3.	O
Prostate	O
CA:	O
father	O
and	O
brother	O
4.	O
CAD:	O
brother	O
(has	O
required	O
2	O
stents)	O
Physical	O
Exam:	O
Exam	O
on	O
Admission:	O
T	O
100.7,	O
BP	O
180/80,	O
HR	O
115,	O
RR	O
24,	O
100%	O
RA	O
GEN:	O
elderly	O
male,	O
sitting	O
up	O
in	O
bed,	O
difficulty	O
speaking	O
full	O
sentences.	O
shortness	O
of	O
breath	O
with	O
sitting	O
up	O
to	O
side	O
of	O
bed,	O
improves	O
with	O
rest.	O
CV:	O
tachy,	O
no	O
murmurs,	O
normal	O
s1/se	O
Pulm:	O
decreased	O
BS	O
r	O
base.	O
ronchi	O
rml.	O
diffuse	O
exp	O
wheeze	O
b/l	O
lung	O
fields	O
with	O
tight	O
air	O
movement.	O
audible	O
air	O
flow	O
but	O
diminished	O
throughout.	O
ABD:	O
soft,	O
NT/ND.	O
NABS	O
Ext:	O
no	O
edema,	O
warm	O
well	O
perfused	O
neuro:	O
pleasant,	O
alert	O
and	O
oriented.	B-Delirium
CNII-XII	O
intact.	O
motor	O
fn	O
full	O
skin:	O
normal	O
affect:	O
normal	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
---------	O
___	O
02:40PM	O
GLUCOSE-118*	O
UREA	O
N-11	O
CREAT-1.0	O
SODIUM-139	O
POTASSIUM-4.1	O
CHLORIDE-102	O
TOTAL	O
CO2-26	O
ANION	O
GAP-15	O
___	O
04:17PM	O
LACTATE-1.3	O
___	O
02:40PM	O
WBC-9.9	O
RBC-4.75	O
HGB-14.2	O
HCT-40.9	O
MCV-86	O
MCH-29.9	O
MCHC-34.8	O
RDW-12.9	O
___	O
02:40PM	O
NEUTS-81.9*	O
LYMPHS-9.0*	O
MONOS-8.0	O
EOS-0.6	O
BASOS-0.6	O
___	O
02:40PM	O
PLT	O
COUNT-166	O
___	O
02:40PM	O
___	O
PTT-27.3	O
___	O
___	O
4:01	O
pm	O
Influenza	O
A/B	O
by	O
___	O
Source:	O
Nasopharyngeal	O
aspirate.	O
TWO	O
SAMPLES	O
COMBINED.	O
SECOND	O
SAMPLE	O
COLLECTED	O
___	O
10A.	O
**FINAL	O
REPORT	O
___	O
DIRECT	O
INFLUENZA	O
A	O
ANTIGEN	O
TEST	O
(Final	O
___:	O
Negative	O
for	O
Influenza	O
A	O
viral	O
antigen.	O
DIRECT	O
INFLUENZA	O
B	O
ANTIGEN	O
TEST	O
(Final	O
___:	O
NEGATIVE	O
FOR	O
INFLUENZA	O
B	O
VIRAL	O
ANTIGEN.	O
Reports:	O
--------	O
___-	O
CTA-	O
No	O
PE.	O
Distorted	O
anatomy	O
secondary	O
to	O
prior	O
right	O
lower	O
lobectomy.	O
Unchanged	O
residual	O
right	O
lung	O
bronchiectasis.	O
___-	O
CHEST	O
PORTABLE:	O
Comparison	O
is	O
made	O
to	O
prior	O
examination	O
of	O
___.	O
The	O
patient	O
is	O
status	O
post	O
right	O
lower	O
lobectomy.	O
There	O
is	O
shift	O
of	O
the	O
heart	O
and	O
the	O
mediastinal	O
to	O
the	O
right.	O
This	O
is	O
unchanged	O
in	O
appearance.	O
There	O
is	O
no	O
evidence	O
for	O
consolidation.	O
No	O
pleural	O
effusion	O
is	O
identified.	O
There	O
are	O
old	O
rib	O
fractures	O
and	O
post-surgical	O
changes	O
in	O
the	O
ribs	O
involving	O
the	O
fifth	O
through	O
eighth	O
ribs	O
on	O
the	O
right.	O
Again,	O
these	O
are	O
stable.	O
IMPRESSION:	O
1.	O
No	O
acute	O
intrathoracic	O
process.	O
2.	O
Post-surgical	O
changes	O
are	O
stable.	O
___-	O
EKG	O
-	O
reviewed	O
by	O
me,	O
demonstrates	O
sinus	O
tachycardia.	O
normal	O
axis.	O
diffuse	O
ST	O
dep	O
infero-laterally,	O
also	O
seen	O
on	O
prior	O
EKG	O
dated	O
___/P:	O
This	O
is	O
a	O
___	O
y/o	O
M	O
with	O
h/o	O
bronchiectasis,	O
s/p	O
RLL	O
lobectomy,	O
reactive	O
airway	O
disease,	O
FEV1	O
30%	O
predicted,	O
who	O
presents	O
with	O
complaint	O
of	O
increasing	O
shortness	O
of	O
breath	O
x	O
1	O
day	O
1.	O
Bronchiectasis	O
with	O
acute	O
exacerbation/Hemoptysis/Dyspnea	O
on	O
exertion/reactive	O
airways	O
disease:	O
Precipitant	O
appears	O
to	O
be	O
URI/bronchitis.	O
Patient	O
also	O
reports	O
cold	O
air	O
exacerbates.	O
Not	O
taking	O
his	O
advair	O
and	O
poor	O
inhaler	O
technique.	O
CTA	O
without	O
evidence	O
pneumonia,	B-Lower_respiratory_tract_infection
PE.	O
ECG	O
without	O
ischemic	O
changes	O
Treated	O
with:	O
--levofloxacin	O
x	O
7	O
days	O
--prednisone	O
taper	O
--advair	O
--Atrovent	O
--	O
spacer	O
given	O
--Albuterol	O
PRN	O
--Ruled	O
out	O
for	O
influenza	O
by	O
DFA	O
2.	O
Acute	O
Renal	O
Failure	O
Likely	O
due	O
to	O
dehydration,	O
which	O
improved	O
rapidly	O
with	O
IV	O
hydration	O
3.	O
BPH:	O
finasteride	O
Physical	O
therapy	O
assessed	O
him	O
as	O
safe	O
discharge	O
on	O
___	O
for	O
home	O
discharge.	O
Medications	O
on	O
Admission:	O
1.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
2.	O
Hydrocodone-Acetaminophen	O
___	O
mg	O
q4prn	O
pain.	O
3.	O
Finasteride	O
5	O
mg	O
PO	O
DAILY	O
4.	O
Fluticasone-Salmeterol	O
250-50	O
mcg/Dose	O
Inh	O
DAILY	O
5.	O
Albuterol-Ipratropium	O
2.5-0.5	O
mg/3	O
mL	O
q6prn	O
6.	O
Cefaclor	O
250mg	O
TID	O
(since	O
___	O
Discharge	O
Medications:	O
1.	O
Finasteride	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
Levofloxacin	O
250	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily)	O
for	O
2	O
days.	O
Disp:*4	O
Tablet(s)*	O
Refills:*0*	O
3.	O
Omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
once	O
a	O
day	O
for	O
14	O
days.	O
Disp:*14	O
Capsule,	O
Delayed	O
Release(E.C.)(s)*	O
Refills:*0*	O
4.	O
Prednisone	O
10	O
mg	O
Tablet	O
Sig:	O
ASDIR	O
Tablet	O
PO	O
once	O
a	O
day:	O
20mg	O
x	O
2	O
days	O
10mg	O
x	O
3	O
days.	O
Disp:*7	O
Tablet(s)*	O
Refills:*2*	O
5.	O
Fluticasone-Salmeterol	O
250-50	O
mcg/Dose	O
Disk	O
with	O
Device	O
Sig:	O
One	O
(1)	O
Disk	O
with	O
Device	O
Inhalation	O
BID	O
(2	O
times	O
a	O
day).	O
Disp:*60	O
Disk	O
with	O
Device(s)*	O
Refills:*2*	O
6.	O
Albuterol	O
90	O
mcg/Actuation	O
Aerosol	O
Sig:	O
___	O
puffs	O
Inhalation	O
every	O
four	O
(4)	O
hours	O
as	O
needed	O
for	O
shortness	O
of	O
breath	O
or	O
wheezing.	O
___	O
MDI*	O
Refills:*3*	O
7.	O
Atrovent	O
HFA	O
17	O
mcg/Actuation	O
Aerosol	O
Sig:	O
One	O
(1)	O
puff	O
Inhalation	O
every	O
six	O
(6)	O
hours.	O
___	O
MDI*	O
Refills:*2*	O
8.	O
Outpatient	O
Physical	O
Therapy	O
Diagnosis:	O
Bronchiectasis	O
Physical	O
Rehabilitation	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
1.	O
Bronchiectasis	O
with	O
acute	O
exacerbation	O
2.	O
Hemoptysis	O
Secondary:	O
1.	O
BPH	O
(Benign	O
Prostatic	O
Hypertrophy	O
2.	O
COPD	O
3.	O
Acute	O
Renal	O
Failure	O
Discharge	O
Condition:	O
Stable,	O
ambulating	O
Discharge	O
Instructions:	O
Follow	O
up	O
as	O
below.	O
Contact	O
your	O
doctor	O
if	O
you	O
have	O
worsening	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
fevers,	O
chill	O
or	O
any	O
other	O
new	O
concerning	O
symptoms.	O
All	O
medications	O
as	O
prescribed.	O
Please	O
note:	O
1.	O
You	O
should	O
take	O
the	O
advair	O
every	O
day	O
as	O
prescribed,	O
not	O
just	O
when	O
you	O
feel	O
symptoms.	O
2.	O
Use	O
the	O
combivent	O
as	O
discussed.	O
Use	O
the	O
spacer	O
3.	O
Take	O
the	O
prednisone.	O
This	O
medication	O
will	O
be	O
tapered	O
down.	O
4.	O
Take	O
the	O
levofloxacin,	O
antibiotic,	O
as	O
prescribed.	O
Finish	O
all	O
pills,	O
even	O
if	O
you	O
feel	O
well	O
Followup	O
Instructions:	O
___	O

